BofA raised the firm’s price target on Thermo Fisher (TMO) to $560 from $545 and keeps a Buy rating on the shares after the company reported a “strong” Q2 and updated its FY25 guidance. The “big news” was that Thermo Fisher “semi-surprisingly” provided an long-range plan update, which was very well-received and relieved a “major overhang,” says the analyst, who thinks the company “threaded the needle on new LRP messaging.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $567 from $553 at Baird
- Thermo Fisher price target lowered to $565 from $570 at Wells Fargo
- Thermo Fisher Scientific Reports Steady Q2 2025 Growth
- Thermo Fisher’s Earnings Call Highlights Growth and Challenges
- Thermo Fisher’s Strong Q2 Performance and Strategic Forecast Adjustments Justify Buy Rating